This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Share
Stay up to date

Home
Topics
Webinars/Videos
Infographics
Articles
Case Studies
Forum
Faculty
Unblocked
Webinar
Stay up to date

Articles

Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

Lee YJ, Cho JY, You SC, et al.

Journal:

Eur Heart J

First published: December 19, 2022 DOI: 10.1093/eurheartj/ehac709

Abstract

You might also like...

Running time: 3 minutes, 26 seconds
Webinars/Videos
The SANTORINI Study: Why Are Lipid Control Therapies Not Working?
In this video, we summarize the results from the SANTORINI trial which documents the effectiveness of current treatment practice in managing LDL-C levels for patients in the higher CV risk categories in and how care may be improved.
Lee YJ, Cho JY, You SC, et al.
Journal:
Eur Heart J

First published: December 19, 2022 DOI: 10.1093/eurheartj/ehac709
View
- Share
Infographics
Proprotein Convertase Subtilisin/Kexin Type 9 in Cholesterol Homeostasis, Inflammation, and Thrombosis Associated with Cardiovascular Diseases
An overview of molecular functions and therapeutic strategies
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in cholesterol homeostasis and inflammation, platelet activation, and atherosclerosis disease progression.
This infographic presents the physiological functions and molecular features that make PCSK9 an attractive therapeutic target for cardiovascular diseases.
Various strategies for targeting PCSK9 and clinical trials involving PCSK9-inhibitors are also delineated.
Lee YJ, Cho JY, You SC, et al.
Journal:
Eur Heart J

First published: December 19, 2022 DOI: 10.1093/eurheartj/ehac709
View
- Share
Case Studies
Quiz of the month – May 2022
Take this short quiz to test your knowledge on some of the latest peer-reviewed published literature related to ASCVD and Lipidology.
Lee YJ, Cho JY, You SC, et al.
Journal:
Eur Heart J

First published: December 19, 2022 DOI: 10.1093/eurheartj/ehac709
Take
- Share

How would you rate this content?

© John Wiley & Sons, Ltd. All rights reserved.
Privacy Policy
Terms of use
Stay up to date
Cookie Preferences
This Knowledge Hub is supported by Novartis.